Patents by Inventor Monica Rixman Swinney

Monica Rixman Swinney has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11901060
    Abstract: The present disclosure relates to systems and methods for controlling physiological glucose concentrations in a patient.
    Type: Grant
    Filed: December 14, 2018
    Date of Patent: February 13, 2024
    Assignee: Ypsomed AG
    Inventors: Yamei Chen, Haoda Fu, Parag Garhyan, Ahmad Mohamad Haidar, Richard Earl Jones, Jr., Christopher Kovalchick, Marie Kearney Schiller, Monica Rixman Swinney, Howard Allan Wolpert
  • Publication number: 20240000352
    Abstract: Devices and methods are described for providing continuous measurement of an analyte concentration. In some embodiments, the device has a sensing mechanism and a sensing membrane that includes at least one surface-active group-containing polymer and that is located over the sensing mechanism. The sensing membrane may have a bioprotective layer configured to substantially block the effect and/or influence of non-constant noise-causing species.
    Type: Application
    Filed: June 30, 2023
    Publication date: January 4, 2024
    Inventors: Robert Boock, Monica Rixman Swinney, Huashi Zhang, Michael J. Estes, Kristina Lawrence
  • Publication number: 20230277803
    Abstract: A catheter for use in medical applications is disclosed. The catheter comprises tubing with a tip hole at one end and an end portion at the other end. Fluid exits the catheter at the tip hole thereof. One or more alternative fluid pathway(s) are provided on the sidewall of the catheter to permit outflow of fluid medication from the catheter to ensure proper delivery of the medication to the intended target area, particularly when the tip opening is occluded or restricted for any reason.
    Type: Application
    Filed: May 11, 2023
    Publication date: September 7, 2023
    Applicant: BECTON, DICKINSON AND COMPANY
    Inventors: Joshua HORVATH, Victor POLITIS, Stephen RICHARDS, Ronald PETTIS, Gary SEARLE, Monica RIXMAN SWINNEY, Natasha BOLICK
  • Patent number: 11730407
    Abstract: Devices and methods are described for providing continuous measurement of an analyte concentration. In some embodiments, the device has a sensing mechanism and a sensing membrane that includes at least one surface-active group-containing polymer and that is located over the sensing mechanism. The sensing membrane may have a bioprotective layer configured to substantially block the effect and/or influence of non-constant noise-causing species.
    Type: Grant
    Filed: January 24, 2022
    Date of Patent: August 22, 2023
    Assignee: Dexcom, Inc.
    Inventors: Robert Boock, Monica Rixman Swinney, Huashi Zhang, Michael J. Estes, Kristina Lawrence
  • Patent number: 11690973
    Abstract: A catheter for use in medical applications is disclosed. The catheter comprises tubing with a tip hole at one end and an end portion at the other end. Fluid exits the catheter at the tip hole thereof. One or more alternative fluid pathway(s) are provided on the sidewall of the catheter to permit outflow of fluid medication from the catheter to ensure proper delivery of the medication to the intended target area, particularly when the tip opening is occluded or restricted for any reason.
    Type: Grant
    Filed: January 4, 2013
    Date of Patent: July 4, 2023
    Assignee: Becton, Dickinson and Company
    Inventors: Joshua Horvath, Victor Politis, Stephen Richards, Ronald Pettis, Gary Searle, Monica Rixman Swinney, Natasha Bolick
  • Patent number: 11510967
    Abstract: The present invention relates to pharmaceutical insulin compositions comprising insulin, a preservative, and at least one selected from the group consisting of aspirin, acetaminophen, dexamethasone, heparin, meloxicam, bromfenac sodium, salicylic acid; and the use of the compositions to treat diabetes.
    Type: Grant
    Filed: August 30, 2018
    Date of Patent: November 29, 2022
    Assignee: Eli Lilly and Company
    Inventors: John Michael Beals, Eric Dwayne Hawkins, Anthony Shane Ransdell, Shantanu Virendra Sule, Monica Rixman Swinney
  • Patent number: 11458281
    Abstract: A catheter for use in medical applications is disclosed. The catheter comprises tubing with a tip hole at one end and an end portion at the other end. Fluid exits the catheter at the tip hole thereof. One or more alternative fluid pathway(s) are provided on the sidewall of the catheter to permit outflow of fluid medication from the catheter to ensure proper delivery of the medication to the intended target area, particularly when the tip opening is occluded or restricted for any reason.
    Type: Grant
    Filed: March 31, 2017
    Date of Patent: October 4, 2022
    Assignee: BECTON, DICKINSON AND COMPANY
    Inventors: Joshua Horvath, Victor Politis, Stephen Richards, Ronald Pettis, Gary Searle, Monica Rixman Swinney, Natasha Bolick
  • Publication number: 20220175891
    Abstract: The present invention relates to pharmaceutical insulin compositions comprising insulin, a preservative, and at least one selected from the group consisting of aspirin, acetaminophen, dexamethasone, heparin, meloxicam, bromfenac sodium, salicylic acid; and the use of the compositions to treat diabetes.
    Type: Application
    Filed: December 15, 2021
    Publication date: June 9, 2022
    Inventors: John Michael BEALS, Eric Dwayne HAWKINS, Anthony Shane RANSDELL, Shantanu Virendra SULE, Monica Rixman SWINNEY
  • Publication number: 20220160954
    Abstract: Drug infusion systems are disclosed including an infusion head configured to deliver a primary drug and a secondary drug to a patient's subcutaneous tissue. The secondary drug may be provided in a controlled-release material and/or a drug-containing reservoir. Methods for assembling and using such drug infusion systems are also disclosed. The secondary drug may extend the wear time of the drug infusion systems.
    Type: Application
    Filed: April 15, 2020
    Publication date: May 26, 2022
    Inventors: Mary Teresa CARTER, Daniel Morris HARTMANN, Kristine Alina Bunker MOORE, Monica Rixman SWINNEY
  • Publication number: 20220142532
    Abstract: Devices and methods are described for providing continuous measurement of an analyte concentration. In some embodiments, the device has a sensing mechanism and a sensing membrane that includes at least one surface-active group-containing polymer and that is located over the sensing mechanism. The sensing membrane may have a bioprotective layer configured to substantially block the effect and/or influence of non-constant noise-causing species.
    Type: Application
    Filed: January 24, 2022
    Publication date: May 12, 2022
    Inventors: Robert Boock, Monica Rixman Swinney, Huashi Zhang, Michael J. Estes, Kristina Lawrence
  • Publication number: 20210345916
    Abstract: Membrane systems incorporating silicone polymers are described for use in implantable analyte sensors. Some layers of the membrane system may comprise a blend of a silicone polymer with a hydrophilic polymer, for example, a triblock poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) polymer. Such polymeric blends provide for both high oxygen solubility and aqueous analyte solubility.
    Type: Application
    Filed: May 25, 2021
    Publication date: November 11, 2021
    Inventors: Robert J. Boock, Monica Rixman Swinney
  • Patent number: 11045601
    Abstract: An insulin infusion set (IIS) device with one or more features designed to achieve longevity in a patients continuous subcutaneous insulin infusion (CSII) site viability. One exemplary feature is an adsorbent material configured to adsorb phenolic excipients (e.g., m-cresol or other preservatives) from the insulin formulation. The adsorbent material may be positioned along a fluid pathway specifically designed to increase and/or extend exposure between the insulin formulation and the adsorbent material. Another exemplary feature is a medicament configured to reduce the patients inflammation or slow the progression of the patients inflammatory response. Yet another exemplary feature is a diffusive catheter configured to deliver the insulin formulation in a diffuse manner.
    Type: Grant
    Filed: April 21, 2017
    Date of Patent: June 29, 2021
    Assignee: Eli Lilly and Company
    Inventors: Christopher John Demaria, Daniel Morris Hartmann, Graham Barry Jones, Christopher Kovalchick, Sean Matthew Pszenny, Rhea Sirkar, Monica Rixman Swinney
  • Patent number: 11020026
    Abstract: Membrane systems incorporating silicone polymers are described for use in implantable analyte sensors. Some layers of the membrane system may comprise a blend of a silicone polymer with a hydrophilic polymer, for example, a triblock poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) polymer. Such polymeric blends provide for both high oxygen solubility and aqueous analyte solubility.
    Type: Grant
    Filed: July 18, 2018
    Date of Patent: June 1, 2021
    Assignee: DexCom, Inc.
    Inventors: Robert J. Boock, Monica Rixman Swinney
  • Publication number: 20200359949
    Abstract: The present invention relates generally to biointerface membranes utilized with implantable devices, such as devices for the detection of analyte concentrations in a biological sample. More particularly, the invention relates to novel biointerface membranes, to devices and implantable devices including these membranes, methods for forming the biointerface membranes on or around the implantable devices, and to methods for monitoring glucose levels in a biological fluid sample using an implantable analyte detection device.
    Type: Application
    Filed: July 14, 2020
    Publication date: November 19, 2020
    Inventors: James H. Brauker, Peter C. Simpson, Robert J. Boock, Monica Rixman Swinney, Mark C. Brister
  • Publication number: 20200342974
    Abstract: The present disclosure relates to systems and methods for controlling physiological glucose concentrations in a patient.
    Type: Application
    Filed: December 14, 2018
    Publication date: October 29, 2020
    Inventors: Yamei CHEN, Haoda FU, Parag GARHYAN, Ahmad Mohamad HAIDAR, Richard Earl JONES, Jr., Christopher KOVALCHICK, Marie Kearney SCHILLER, Monica Rixman SWINNEY, Howard Allan WOLPERT
  • Publication number: 20200261545
    Abstract: The present invention relates to pharmaceutical insulin compositions comprising insulin, a preservative, and at least one selected from the group consisting of aspirin, acetaminophen, dexamethasone, heparin, meloxicam, bromfenac sodium, salicylic acid; and the use of the compositions to treat diabetes.
    Type: Application
    Filed: August 3, 2018
    Publication date: August 20, 2020
    Inventors: John Michael BEALS, Eric Dwayne HAWKINS, Anthony Shane RANSDELL, Shantanu Virendra SULE, Monica Rixman SWINNEY
  • Publication number: 20190091446
    Abstract: The present disclosure relates to a tube management device for an infusion set that includes a holding member attachable to the patient and which defines a holding chamber for the tube. The tube may be engaged and disengaged with the device while the lube is operably connected to convey medication. The device may also allow a) the length of flexible tube controlled by the device and b) the position of the final exit of the tube from the holding member relative to the initial entry of the tube into the holding member to both be selectively adjusted. In some embodiments, tire holding chamber is defined by a plurality of channels which may be either non-intersecting or intersecting channels.
    Type: Application
    Filed: April 20, 2017
    Publication date: March 28, 2019
    Inventors: Daniel Morris HARTMANN, Lampros C KOURTIS, Sean Matthew PSZENNY, Monica Rixman SWINNEY
  • Publication number: 20190054233
    Abstract: An insulin infusion set (IIS) device with one or more features designed to achieve longevity in a patients continuous subcutaneous insulin infusion (CSII) site viability. One exemplary feature is an adsorbent material configured to adsorb phenolic excipients (e.g., m-cresol or other preservatives) from the insulin formulation. The adsorbent material may be positioned along a fluid pathway specifically designed to increase and/or extend exposure between the insulin formulation and the adsorbent material. Another exemplary feature is a medicament configured to reduce the patients inflammation or slow the progression of the patients inflammatory response. Yet another exemplary feature is a diffusive catheter configured to deliver the insulin formulation in a diffuse manner.
    Type: Application
    Filed: April 21, 2017
    Publication date: February 21, 2019
    Inventors: Christopher John DEMARIA, Daniel Morris HARTMANN, Graham Barry JONES, Christopher KOVALCHICK, Sean Matthew PSZENNY, Rhea SIRKAR, Monica Rixman SWINNEY
  • Publication number: 20180317824
    Abstract: Membrane systems incorporating silicone polymers are described for use in implantable analyte sensors. Some layers of the membrane system may comprise a blend of a silicone polymer with a hydrophilic polymer, for example, a triblock poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) polymer. Such polymeric blends provide for both high oxygen solubility and aqueous analyte solubility.
    Type: Application
    Filed: July 18, 2018
    Publication date: November 8, 2018
    Inventors: Robert J. Boock, Monica Rixman Swinney
  • Publication number: 20180303394
    Abstract: The present invention relates generally to biointerface membranes utilized with implantable devices, such as devices for the detection of analyte concentrations in a biological sample. More particularly, the invention relates to novel biointerface membranes, to devices and implantable devices including these membranes, methods for forming the biointerface membranes on or around the implantable devices, and to methods for monitoring glucose levels in a biological fluid sample using an implantable analyte detection device.
    Type: Application
    Filed: June 25, 2018
    Publication date: October 25, 2018
    Inventors: James H. Brauker, Peter C. Simpson, Robert J. Boock, Monica Rixman Swinney, Mark C. Brister